夏淼
Lv1
60 积分
2025-04-09 加入
-
9MW2821, a next-generation Nectin-4 targeting antibody-drug conjugate, in patients with advanced solid tumors: a first-in-human, open label, multicenter, phase Ⅰ/Ⅱ study
1天前
已完结
-
9MW2821, a next-generation Nectin-4 targeting antibody-drug conjugate, in patients with advanced solid tumors: a first-in-human, open label, multicenter, phase Ⅰ/Ⅱ study
2天前
已完结
-
Docetaxel as part of first-line chemotherapy for gastric cancer
6天前
已关闭
-
TFOX versus FOLFOX in first-line treatment of patients with advanced HER2-negative gastric or gastro-oesophageal junction adenocarcinoma (PRODIGE 51- FFCD-GASTFOX): an open-label, multicentre, randomised, phase 3 trial
6天前
已关闭
-
Radiotherapy promotes cuproptosis and synergizes with cuproptosis inducers to overcome tumor radioresistance
20天前
已完结
-
CDK4 selective inhibition improves preclinical anti-tumor efficacy and safety
21天前
已完结
-
Cancer cell-derived arginine fuels polyamine biosynthesis in tumor-associated macrophages to promote immune evasion
21天前
已完结